Beck Bode LLC’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Beck Bode LLC's PFE Position: Q1 2023 in Review
Beck Bode LLC sold out of Pfizer (PFE) in Q1 2023, closing a stake of 6,114 shares — an estimated $313K sold.
Beck Bode LLC first reported a position in PFE in Q4 2018 and held it in 16 quarters. The position peaked at $1.57M in Q4 2018. 3,105 funds tracked by Wall St. Rank hold PFE as of Q1 2023.
- Beck Bode LLC reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
- Beck Bode LLC sold 6,114 Pfizer shares in Q1 2023, an estimated $313K.
- Beck Bode LLC first reported a position in Pfizer in Q4 2018 and held it in 16 quarters.
- Beck Bode LLC's Pfizer position peaked at $1.57M in Q4 2018.
- 3,105 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.
Based on Beck Bode LLC's 13F filing for Q1 2023, filed 3 May 2023.